New London ― Dean Festa got lucky when he sought to make a change in his life insurance policy. His insurance agent told him ...

"attachment_87300" align="aligncenter" width="600" class="popover-hover"] Pictured (from left) are Dr. Tao Cui and Dr. Mary ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Clients sit on our EMSELLA chair fully clothed for treatment, with 95% satisfaction rates and 75% reduction in pad usage.

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

Nine of 11 patients in new brain cancer trial saw their tumors shrink by at least half. One really beat the odds.

Brooke began taking OGSIVEO on December 30, 2023, just a month after it was approved by the FDA for adults with progressing ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

“Use of active surveillance has increased over the last 15 years for men with low-risk prostate cancer, and it is now the ...

Key Takeaways Men’s incontinence is a common issue affecting many individuals globally. Understanding the types and causes ...